
Port NOLA reaches cargo and terminal milestones
The Port of New Orleans (Port NOLA) ended the year in 2021 strengthening its economic benefit to the region and state with wins across all four of its lines of business: cargo,
The Port of New Orleans (Port NOLA) ended the year in 2021 strengthening its economic benefit to the region and state with wins across all four of its lines of business: cargo,
Both ocean-going and inland river cruises are scheduled to make a comeback at the Port of New Orleans (Port NOLA) in 2022. The arrival of the Norwegian Breakaway on November 21 at
Norwegian Prima, the first of six ships in Norwegian Cruise Line’s first new class of vessels in nearly 10 years, has been floated out from her building dock at Fincantieri’s shipyard in
As cruises from U.S. ports slowly resume, cruise lines have to negotiate a tricky path between Centers for Disease Control and Prevention (CDC) restrictions and “no vaccine passport” laws imposed by some
May 2021 As the pandemic saga continues to unfold, the Centers for Disease Control and Prevention (CDC) has been under gathering pressure to end its ban on cruising, which has had a devastating economic
While still grappling with the issues of how to meet CDC mandates and resume cruises from U.S. ports this year, Norwegian Cruise Line is also looking ahead to summer 2022. It has
Norwegian Cruise Line Holdings Ltd., which operates the Norwegian Cruise Line, Oceania Cruises and Regent Seven Seas Cruises brands, today announces is providing $10 million in cash support to six Alaska port
Norwegian Cruise Lines Holdings Ltd, (NYSE:NCLH) has been quick to respond to the CDC’s updated guidance on cruising. Today it wrote the CDC outlining its plan to resume cruising from U.S. ports,
Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) is partnering with AtmosAir Solutions to install continuous disinfection air purification systems across the 28 ships in its three brands, Norwegian Cruise Line, Oceania Cruises
Prices of cruise lines stocks soared on the New York Stock Exchange today as Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced that their mRNA-based vaccine candidate had demonstrated evidence